Smart Cells Releases 1st Sample to Treat Autism
Author: Smart Cells
Published: 2018/03/28
Topic: Regenerative Medicine - Publications List
Page Content: Synopsis Introduction Main
Synopsis: Private cord blood company, Smart Cells, has released their 20th sample of stem cells collected from cord blood and tissue to a patient to treat autism.
Introduction
Private cord blood company, Smart Cells, has released their 20th sample of stem cells collected from cord blood and tissue to a patient to treat autism. This is the company's first sample to be released and infused for the condition. This release closely coincides with World Autism Awareness Day on the 2nd April, for which Smart Cells have released a simple informational guide on autism for parents.
Main Item
Autism Spectrum Disorder, more commonly known as simply "autism", is a group of developmental brain disorders that affects around 700,000 people in the UK. It affects a person's ability to read body language, understand facial expressions and communicate effectively, and also can cause repetitive, sometimes harmful, behaviour. It is currently incurable but has previously only been treatable through therapy and interventions.
In a breakthrough for stem cell science and the treatment of autism, Smart Cells has released their first sample to infuse in a 5 year old boy with autism at Duke University, North Carolina, USA in March 2018.
With this release, they celebrate their 20th successful sample to be released to a customer from whom cord blood and tissue was collected at birth, closely following the release of a sample that was recently sent to a 3 year old girl at Duke University for a cerebral palsy treatment.
Previous studies have shown that not only are the infusions safe and feasible, which is a hugely important first step in cord blood transplants, but that recipients of the transfusion have also shown improvements in the condition of autism, with reductions in symptoms such as repetitive behaviour and improvements in their general behaviour. The parents and researchers at Duke University noted behavioural improvements in 70% of the 25 children in the study.
The rationale behind using stem cells as treatment is that it can decrease inflammation that is a consistent finding in the brain and gut of people with autism, in turn helping to alleviate their symptoms.
In order to help parents who have children with autism to find support and understand the condition of autism, Smart Cells have released a simple guide to autism that breaks down the facts and stats, explains where parents can turn to find help and what treatments are currently available.
Dr. Ann Smith, Scientific Director at Smart Cells, commented:
"It's a huge breakthrough in the science of autism for us to release our first sample to treat the condition. There are currently further ongoing studies into using stem cells in the treatment of autism, and we expect to see even more promising and positive results in future."
"We hope that by showing our support for World Autism Day with our simple Parents' Guide to Autism, we'll also be able to help parents who don't currently have access to this kind of medical treatment, instead guiding them to find support where they can."
Attribution/Source(s):
This quality-reviewed publication was selected for publishing by the editors of Disabled World (DW) due to its significant relevance to the disability community. Originally authored by Smart Cells, and published on 2018/03/28, the content may have been edited for style, clarity, or brevity. For further details or clarifications, Smart Cells can be contacted at smartcells.com. NOTE: Disabled World does not provide any warranties or endorsements related to this article.
1 - New Ethical Framework Introduced for Stem Cell-Based Embryo Research - A groundbreaking code of practice has been introduced for the use of stem cell-based embryo models in research.
2 - Making Stem Cells Behave Like Human Embryos - Human pluripotent stem cells in a lab can initiate a process resembling the gastrulation phase - where cells begin differentiating into new cell types - much earlier than occurs in mother nature.
3 - Organoids: Fitting a Mini Brain with a Tiny Cap - A tiny EEG electrode cap was created to measure activity in an organoid brain model the size of a pen dot to lead to a better understanding of neural disorders and how chemicals affect the brain.
Information and Page References
Disabled World (DW) is a comprehensive online resource that provides information and news related to disabilities, assistive technologies, and accessibility issues. Founded in 2004 our website covers a wide range of topics, including disability rights, healthcare, education, employment, and independent living, with the goal of supporting the disability community and their families.
Cite This Page (APA): Smart Cells. (2018, March 28). Smart Cells Releases 1st Sample to Treat Autism. Disabled World (DW). Retrieved January 14, 2025 from www.disabled-world.com/news/research/stemcells/smartcells.php
Permalink: <a href="https://www.disabled-world.com/news/research/stemcells/smartcells.php">Smart Cells Releases 1st Sample to Treat Autism</a>: Private cord blood company, Smart Cells, has released their 20th sample of stem cells collected from cord blood and tissue to a patient to treat autism.
While we strive to provide accurate and up-to-date information, it's important to note that our content is for general informational purposes only. We always recommend consulting qualified healthcare professionals for personalized medical advice. Any 3rd party offering or advertising does not constitute an endorsement.